Shandong Weigao Group Medical Polymer Company Limited (1066.HK)

Name: Shandong Weigao Group Medical Polymer Company Limited Financial Statements
Creator: Quarter Results

Healthcare | Medical Instruments Supplies

Latest reporting period: 2026-04-08

Latest Quarter

2026-04-08

Revenue

$6.6B

Net Income

$1.0B

Operating Margin

17.7%

Free Cash Flow

$2.2B

Debt / Assets

28.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Income Statement (Quarterly)	2026-04-08	2025-12-31	2025-06-30	2025-03-31
Revenue	6,644,048,000	6,632,313,865	6,644,048,000	3,322,024,000
Cost of Revenue	3,340,540,000	3,753,981,516	3,340,540,000	1,670,270,000
Gross Profit	3,303,508,000	2,878,332,348	3,303,508,000	1,651,754,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,812,231,000	1,852,531,746	1,812,231,000	906,115,500
Operating Expenses	2,127,763,000	2,178,064,545	2,127,763,000	1,063,881,500
Operating Income	1,175,745,000	700,267,802	1,175,745,000	587,872,500
Interest Expense	0	136,760,629	116,773,000	0
Income Before Tax	1,225,904,000	792,150,855	1,225,904,000	612,952,000
Income Tax Expense	168,919,000	149,339,214	168,919,000	84,459,500
Net Income	1,008,317,000	593,817,900	1,008,317,000	504,158,500
Per Share
EPS	0.22	0.13	0.22	0.11
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	13,042,370,686	13,087,071,000	13,229,453,000	13,619,007,000	13,151,719,000
Cost of Revenue	7,114,313,672	6,506,440,000	6,586,420,000	6,505,925,000	5,882,315,000
Gross Profit	5,928,057,012	6,580,631,000	6,643,033,000	7,113,082,000	7,269,404,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	3,459,170,216	3,628,787,000	3,832,220,000	3,543,766,000	3,773,472,000
Operating Expenses	4,096,180,651	4,194,457,000	4,345,928,000	3,965,620,000	4,152,392,000
Operating Income	1,831,876,358	2,386,174,000	2,180,397,000	3,561,415,000	3,117,012,000
Interest Expense	249,232,214	249,572,000	272,971,000	191,401,000	140,396,000
Income Before Tax	1,978,917,656	2,553,748,000	2,369,187,000	3,317,901,000	2,841,721,000
Income Tax Expense	312,489,547	391,032,000	307,585,000	424,267,000	415,093,000
Net Income	1,570,484,217	2,066,668,000	2,001,906,000	2,723,309,000	2,244,778,000
Per Share
EPS	0.35	0.46	0.44	0.60	0.50
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	8,986,981,203	7,780,310,000	6,988,731,000	6,862,278,000
Short Term Investments	883,427,789	541,498,000	344,582,000	495,337,000
Net Receivables	8,284,872,953	7,455,486,000	5,960,128,000	5,735,233,000
Inventory	2,516,149,008	2,528,425,000	2,495,352,000	2,315,343,000
Total Current Assets	20,671,430,956	19,442,540,000	18,634,291,000	18,090,392,000
Property Plant Equipment	7,532,216,085	7,084,117,000	7,006,731,000	7,313,003,000
Goodwill and Intangibles	4,748,190,520	5,135,409,000	5,064,970,000	5,360,917,000
Total Assets	36,063,530,253	34,759,849,000	33,670,231,000	33,195,926,000
Liabilities
Account Payables	1,219,868,665	4,294,068,000	4,319,784,000	1,809,704,000
Short Term Debt	1,380,504,360	1,241,799,000	2,573,337,000	990,131,000
Total Current Liabilities	5,474,723,216	6,080,504,000	7,582,041,000	5,934,523,000
Long Term Debt	4,606,986,136	2,951,347,000	1,595,980,000	3,501,266,000
Total Liabilities	10,232,854,990	9,418,283,000	9,677,526,000	9,749,323,000
Shareholders Equity
Retained Earnings	0	19,852,418,000	18,627,532,000	17,312,614,000
Total Shareholders Equity	24,118,491,061	23,751,643,000	22,449,121,000	21,668,937,000

Balance sheet annual history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	8,986,981,203	7,780,310,000	6,988,731,000	6,862,278,000	6,628,927,000
Short Term Investments	883,427,789	541,498,000	344,582,000	495,337,000	429,752,000
Net Receivables	8,284,872,953	7,455,486,000	5,960,128,000	5,735,233,000	0
Inventory	2,516,149,008	2,528,425,000	2,495,352,000	2,315,343,000	1,734,557,000
Total Current Assets	20,671,430,956	19,442,540,000	18,634,291,000	18,090,392,000	16,113,346,000
Property Plant Equipment	7,532,216,085	7,084,117,000	7,006,731,000	7,313,003,000	6,663,417,000
Goodwill and Intangibles	4,748,190,520	5,135,409,000	5,064,970,000	5,360,917,000	5,147,074,000
Total Assets	36,063,530,253	34,759,849,000	33,670,231,000	33,195,926,000	30,367,058,000
Liabilities
Account Payables	1,219,868,665	4,294,068,000	4,319,784,000	1,809,704,000	1,733,440,000
Short Term Debt	1,380,504,360	1,241,799,000	2,573,337,000	990,131,000	624,316,000
Total Current Liabilities	5,474,723,216	6,080,504,000	7,582,041,000	5,934,523,000	5,112,975,000
Long Term Debt	4,606,986,136	2,951,347,000	1,595,980,000	3,501,266,000	3,513,094,000
Total Liabilities	10,232,854,990	9,418,283,000	9,677,526,000	9,749,323,000	9,459,608,000
Shareholders Equity
Retained Earnings	0	19,852,418,000	18,627,532,000	17,312,614,000	0
Total Shareholders Equity	24,118,491,061	23,751,643,000	22,449,121,000	21,668,937,000	19,267,091,000

Cash flow quarterly history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	2,553,748,000	2,369,187,000	3,317,901,000	2,244,778,000
Depreciation & Amortization	971,796,000	911,704,000	802,512,000	723,813,000
Stock Based Compensation	36,020,000	55,459,000	91,767,000	76,492,000
Change in Working Capital	-291,727,000	-315,232,000	-1,136,557,000	-204,934,000
Operating Cash Flow	2,789,971,000	2,798,529,000	2,214,574,000	3,035,163,000
Investing Activities
Capital Expenditure	-596,714,000	-685,664,000	-1,116,239,000	-1,116,882,000
Investments	-596,714,000	-647,577,000	-1,116,239,000	-1,070,684,000
Investing Cash Flow	-1,104,415,000	-1,388,592,000	-2,568,963,000	-1,479,374,000
Financing Activities
Debt Repayment	-102,002,000	-364,530,000	-874,672,000	-706,641,000
Common Stock Issued/Repurchased	-30,434,000	-36,530,000	-70,496,000	188,461,000
Dividends Paid	-870,588,000	-732,633,000	-741,638,000	-653,288,000
Financing Cash Flow	-1,595,939,000	-2,157,858,000	-1,020,957,000	-538,080,000
Summary
Free Cash Flow	2,191,925,000	2,112,865,000	1,098,335,000	1,918,281,000
Net Change in Cash	145,421,000	-723,590,000	-1,279,186,000	963,271,000

Cash flow annual history for Shandong Weigao Group Medical Polymer Company Limited (1066.HK).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	2,553,748,000	2,369,187,000	3,317,901,000	2,244,778,000	2,030,137,000
Depreciation & Amortization	971,796,000	911,704,000	802,512,000	723,813,000	690,694,000
Stock Based Compensation	36,020,000	55,459,000	91,767,000	76,492,000	30,662,000
Change in Working Capital	-291,727,000	-315,232,000	-1,136,557,000	-204,934,000	-262,948,000
Operating Cash Flow	2,789,971,000	2,798,529,000	2,214,574,000	3,035,163,000	2,696,608,000
Investing Activities
Capital Expenditure	-596,714,000	-685,664,000	-1,116,239,000	-1,116,882,000	-995,625,000
Investments	-596,714,000	-647,577,000	-1,116,239,000	-1,070,684,000	-935,598,000
Investing Cash Flow	-1,104,415,000	-1,388,592,000	-2,568,963,000	-1,479,374,000	423,221,000
Financing Activities
Debt Repayment	-102,002,000	-364,530,000	-874,672,000	-706,641,000	-2,593,945,000
Common Stock Issued/Repurchased	-30,434,000	-36,530,000	-70,496,000	188,461,000	258,763,000
Dividends Paid	-870,588,000	-732,633,000	-741,638,000	-653,288,000	-701,349,000
Financing Cash Flow	-1,595,939,000	-2,157,858,000	-1,020,957,000	-538,080,000	-1,793,841,000
Summary
Free Cash Flow	2,191,925,000	2,112,865,000	1,098,335,000	1,918,281,000	1,700,983,000
Net Change in Cash	145,421,000	-723,590,000	-1,279,186,000	963,271,000	0